The company’s Moderate operating performance and financial health, combined with its High valuation, make the stock appear ...

Trying to figure out whether to buy, sell, or hold Johnson & Johnson? You are not alone. The stock price has been on a bit of ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Patient Investor model based on the published strategy of ...

Johnson & Johnson (JNJ) shares have edged mostly sideways over the past week, finishing at $190.40 in the latest session.

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our P/B Growth Investor model based on the published strategy of ...

Johnson & Johnson ranks highest in Gross Profit and Return on Equity among its peers. It is in the middle for Revenue Growth.

Johnson & Johnson (JNJ) stock is brushing off a beat-and-raised and bull note, while also cooling off from record highs ...

Johnson & Johnson (NYSE:JNJ) announced yesterday that it would spin off its orthopedics business to allow it to become the largest firm of its kind in the world.

Johnson & Johnson (NYSE:JNJ – Get Free Report)’s stock price rose 1.2% during mid-day trading on Tuesday after Guggenheim upgraded the stock from a neutral rating to a buy rating. Guggenheim now has a ...